Biotech firms show interest in developing antibiotics

05/17/2011 | Bloomberg

Biotech companies are increasing research into antibiotics, which large drugmakers are less frequently pursuing because of a lack of revenue opportunities, as strains of drug-resistant bacteria begin to emerge. One such company is Optimer Pharmaceuticals, which expects to get FDA approval by the end of the month for Dificid, an antibiotic against stomach infection.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ